Bio-Rad Laboratories, Inc. (BIO.B) vs Bruker Corporation (BRKR)
- Bio-Rad Laboratories, Inc. BIO.B 364.15 −0.25%
- Bruker Corporation BRKR 54.80 −3.08%
Bio-Rad Laboratories, Inc. and Bruker Corporation are both Medical Devices companies. Bio-Rad Laboratories, Inc. is the larger, with a market value of $10.3B against $8.6B — 1.2× the size. Bruker Corporation has negative trailing earnings, so its P/E is not meaningful; Bio-Rad Laboratories, Inc. trades at 43.7×. Bruker Corporation grew revenue faster over the last twelve months: 1.65% against 1.37%. Bio-Rad Laboratories, Inc. has the higher net margin (8.59% vs −3.05%) and the higher return on invested capital (0.49% vs −0.47%). Across the 21 metrics below, Bio-Rad Laboratories, Inc. leads on 15 and Bruker Corporation on 6.
Valuation
Profitability
| Metric | BIO.B | BRKR | Medical Devices median |
|---|---|---|---|
| Gross margin | 51.90% | 46.42% | 56.01% |
| Operating margin | 2.05% | (0.87%) | (15.03%) |
| Net margin | 8.59% | (3.05%) | (20.40%) |
| Free cash flow margin | 13.64% | 2.68% | (7.24%) |
| Return on equity | 3.11% | (5.07%) | (15.32%) |
| Return on assets | 2.17% | (1.73%) | (19.72%) |
| Return on invested capital | 0.49% | (0.47%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack